Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$21.07 USD
+0.35 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $21.08 +0.01 (0.05%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PHG 21.07 +0.35(1.69%)
Will PHG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PHG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHG
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
PHG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
Philips (PHG) Expands Sonicare Portfolio With Latest Launch
Other News for PHG
Pharming Group’s Strategic Financial Maneuver
Artisan International Value Fund Q1 2024 Commentary
Pharming Group Lauded for Rare Disease Treatment
Bullish Two Hundred Day Moving Average Cross - PHG
Philips warning letter could lead to pullback in shares, says Jefferies